Clinical trial
A Prospective, Open, Registry-based Randomized, Controlled, Investigator Initiated Trial of Enavogliflozin(ENVlo) to EvaLuate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients (ENVELOP Study)
NCT06642623 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open, Registry-based Randomized, Controlled, Investigator Initiated Trial of Enavogliflozin(ENVlo) to EvaLuate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients (ENVELOP Study)
- Lead sponsor
- Yonsei University
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 22, 2024
- Completion date
- December 31, 2030
- Enrollment
- 2,862 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.